Health-Chem Corporation
Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts researc… Read more
Market Cap & Net Worth: Health-Chem Corporation (HCLC)
Health-Chem Corporation (PINK:HCLC) has a market capitalization of $0.92 ($0.92) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51136 globally and #15847 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Health-Chem Corporation's stock price $0.00 by its total outstanding shares 9157 (9.16K).
Health-Chem Corporation Market Cap History: 2015 to 2024
Health-Chem Corporation's market capitalization history from 2015 to 2024. Data shows change from $55.86 to $0.92 (-36.47% CAGR).
Health-Chem Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Health-Chem Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of HCLC by Market Capitalization
Companies near Health-Chem Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to Health-Chem Corporation by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Health-Chem Corporation Historical Marketcap From 2015 to 2024
Between 2015 and today, Health-Chem Corporation's market cap moved from $55.86 to $ 0.92, with a yearly change of -36.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $0.92 | 0.00% |
| 2023 | $0.92 | 0.00% |
| 2022 | $0.92 | -50.00% |
| 2021 | $1.83 | -97.14% |
| 2020 | $64.10 | +133.33% |
| 2019 | $27.47 | -21.05% |
| 2018 | $34.80 | +80.95% |
| 2017 | $19.23 | -16.00% |
| 2016 | $22.89 | -59.02% |
| 2015 | $55.86 | -- |
End of Day Market Cap According to Different Sources
On Nov 28th, 2025 the market cap of Health-Chem Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $0.92 USD |
| MoneyControl | $0.92 USD |
| MarketWatch | $0.92 USD |
| marketcap.company | $0.92 USD |
| Reuters | $0.92 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.